CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4 Derivatives Options or other derivatives
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K/A Event Material agreement · Unregistered share sale
- S-1/A Offering Registration Statement
- 8-K Event Other events
- S-1 Offering Registration Statement
- 8-K Event Material agreement · Unregistered share sale
- 4 Open-market buy 10% owner bought 1,111,111 shares at $0.45 ($500,000)
- 4 Open-market buy Director bought 55,556 shares at $0.45 ($25,000)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 16,389 shares at $0.45 ($7,375)
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
Page 3 of 78 · 1,549 filings